These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 35876890)

  • 1. APE1 controls DICER1 expression in NSCLC through miR-33a and miR-130b.
    Antoniali G; Dalla E; Mangiapane G; Zhao X; Jing X; Cheng Y; De Sanctis V; Ayyildiz D; Piazza S; Li M; Tell G
    Cell Mol Life Sci; 2022 Jul; 79(8):446. PubMed ID: 35876890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-130b is an EMT-related microRNA that targets DICER1 for aggression in endometrial cancer.
    Li BL; Lu C; Lu W; Yang TT; Qu J; Hong X; Wan XP
    Med Oncol; 2013 Mar; 30(1):484. PubMed ID: 23392577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High copy number variation of cancer-related microRNA genes and frequent amplification of DICER1 and DROSHA in lung cancer.
    Czubak K; Lewandowska MA; Klonowska K; Roszkowski K; Kowalewski J; Figlerowicz M; Kozlowski P
    Oncotarget; 2015 Sep; 6(27):23399-416. PubMed ID: 26156018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired microRNA processing by DICER1 downregulation endows thyroid cancer with increased aggressiveness.
    Ramírez-Moya J; Wert-Lamas L; Riesco-Eizaguirre G; Santisteban P
    Oncogene; 2019 Jul; 38(27):5486-5499. PubMed ID: 30967628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Significance of Apurinic/Apyrimidinic Endodeoxyribonuclease 1 and MicroRNA Axis in Hepatocellular Carcinoma.
    Mangiapane G; Pascut D; Dalla E; Antoniali G; Degrassi M; Crocè LS; De Sanctis V; Piazza S; Canarutto G; Tiribelli C; Tell G
    J Clin Transl Hepatol; 2023 Nov; 11(6):1291-1307. PubMed ID: 37719963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DICER1, DROSHA and miRNAs in patients with non-small cell lung cancer: implications for outcomes and histologic classification.
    Díaz-García CV; Agudo-López A; Pérez C; López-Martín JA; Rodríguez-Peralto JL; de Castro J; Cortijo A; Martínez-Villanueva M; Iglesias L; García-Carbonero R; Fresno Vara JA; Gámez-Pozo A; Palacios J; Cortés-Funes H; Paz-Ares L; Agulló-Ortuño MT
    Carcinogenesis; 2013 May; 34(5):1031-8. PubMed ID: 23349018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological and prognostic significance of microRNA-107 and its relationship to DICER1 mRNA expression in gastric cancer.
    Inoue T; Iinuma H; Ogawa E; Inaba T; Fukushima R
    Oncol Rep; 2012 Jun; 27(6):1759-64. PubMed ID: 22407237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-98-5p contributes to cisplatin resistance in epithelial ovarian cancer by suppressing miR-152 biogenesis via targeting Dicer1.
    Wang Y; Bao W; Liu Y; Wang S; Xu S; Li X; Li Y; Wu S
    Cell Death Dis; 2018 May; 9(5):447. PubMed ID: 29670086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional requirement of dicer1 and miR-17-5p in reactive astrocyte proliferation after spinal cord injury in the mouse.
    Hong P; Jiang M; Li H
    Glia; 2014 Dec; 62(12):2044-60. PubMed ID: 25043492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autophagic degradation of SQSTM1 inhibits ovarian cancer motility by decreasing DICER1 and AGO2 to induce MIRLET7A-3P.
    Liao CC; Ho MY; Liang SM; Liang CM
    Autophagy; 2018; 14(12):2065-2082. PubMed ID: 30081720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-192 directly binds and regulates Dicer1 expression in neuroblastoma.
    Feinberg-Gorenshtein G; Guedj A; Shichrur K; Jeison M; Luria D; Kodman Y; Ash S; Feinmesser M; Edry L; Shomron N; Weizman A; Yaniv I; Avigad S
    PLoS One; 2013; 8(11):e78713. PubMed ID: 24223844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MOV10 binding circ-DICER1 regulates the angiogenesis of glioma via miR-103a-3p/miR-382-5p mediated ZIC4 expression change.
    He Q; Zhao L; Liu X; Zheng J; Liu Y; Liu L; Ma J; Cai H; Li Z; Xue Y
    J Exp Clin Cancer Res; 2019 Jan; 38(1):9. PubMed ID: 30621721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent DICER1 hotspot mutations in endometrial tumours and their impact on microRNA biogenesis.
    Chen J; Wang Y; McMonechy MK; Anglesio MS; Yang W; Senz J; Maines-Bandiera S; Rosner J; Trigo-Gonzalez G; Grace Cheng SW; Kim J; Matzuk MM; Morin GB; Huntsman DG
    J Pathol; 2015 Oct; 237(2):215-25. PubMed ID: 26033159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DICER1 gene and miRNA dysregulation in mesenchymal stem cells of patients with myelodysplastic syndrome and acute myeloblastic leukemia.
    Ozdogan H; Gur Dedeoglu B; Oztemur Islakoglu Y; Aydos A; Kose S; Atalay A; Yegin ZA; Avcu F; Uckan Cetinkaya D; Ilhan O
    Leuk Res; 2017 Dec; 63():62-71. PubMed ID: 29102598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-107, an oncogene microRNA that regulates tumour invasion and metastasis by targeting DICER1 in gastric cancer.
    Li X; Zhang Y; Shi Y; Dong G; Liang J; Han Y; Wang X; Zhao Q; Ding J; Wu K; Fan D
    J Cell Mol Med; 2011 Sep; 15(9):1887-95. PubMed ID: 21029372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-Independent Modulation of DICER1 Expression by hAgo2.
    Yang CH; Li HC; Ku TS; Wu CH; Sim KC; Lo SY
    Mol Cell Biol; 2020 Sep; 40(20):. PubMed ID: 32778571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amplification of hsa-miR-191/425 locus promotes breast cancer proliferation and metastasis by targeting DICER1.
    Zhang X; Wu M; Chong QY; Zhang W; Qian P; Yan H; Qian W; Zhang M; Lobie PE; Zhu T
    Carcinogenesis; 2018 Dec; 39(12):1506-1516. PubMed ID: 30084985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer-associated somatic DICER1 hotspot mutations cause defective miRNA processing and reverse-strand expression bias to predominantly mature 3p strands through loss of 5p strand cleavage.
    Anglesio MS; Wang Y; Yang W; Senz J; Wan A; Heravi-Moussavi A; Salamanca C; Maines-Bandiera S; Huntsman DG; Morin GB
    J Pathol; 2013 Feb; 229(3):400-9. PubMed ID: 23132766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MircoRNA-33a inhibits epithelial-to-mesenchymal transition and metastasis and could be a prognostic marker in non-small cell lung cancer.
    Yang L; Yang J; Li J; Shen X; Le Y; Zhou C; Wang S; Zhang S; Xu D; Gong Z
    Sci Rep; 2015 Sep; 5():13677. PubMed ID: 26330060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hsa-miR-125a-3p and hsa-miR-125a-5p are downregulated in non-small cell lung cancer and have inverse effects on invasion and migration of lung cancer cells.
    Jiang L; Huang Q; Zhang S; Zhang Q; Chang J; Qiu X; Wang E
    BMC Cancer; 2010 Jun; 10():318. PubMed ID: 20569443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.